This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Vapotherm Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vapotherm.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth12.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Vapotherm announces $23M private placement

Feb 08

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Nov 02

Vapotherm draws downgrade at William Blair after 2Q results

Aug 04

Vapotherm: Out Of Air

May 11

Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Jan 24
Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Vapotherm: Hardly Breathing Room

Jul 11

Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

May 10
Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

Vapotherm reports Q1 results

May 05

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Mar 12
The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Mar 11
Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Jan 19
Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

Jan 13

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Dec 14
Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Dec 11
Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Vapotherm shares +9% on higher Q4 guidance

Dec 01

Vapotherm: The Game Has Completely Changed

Nov 13

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vapotherm has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:VAPO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202471-54-21-17N/A
3/31/202470-55-24-21N/A
12/31/202369-58-27-24N/A
9/30/202368-69-37-31N/A
6/30/202366-81-54-47N/A
3/31/202363-108-69-60N/A
12/31/202267-113-92-80N/A
9/30/202270-110-95-85N/A
6/30/202295-98-84-75N/A
3/31/2022103-72-73-66N/A
12/31/2021113-60-61-55N/A
9/30/2021132-58-55-47N/A
6/30/2021124-57-54-45N/A
3/31/2021139-48-59-49N/A
12/31/2020126-52-49-39N/A
9/30/202098-47-51-43N/A
6/30/202078-47-52-45N/A
3/31/202055-52-46-41N/A
12/31/201948-51-44-40N/A
9/30/201947-51-44-40N/A
6/30/201945-48-47-42N/A
3/31/201944-47-44-39N/A
12/31/201842-43-45-40N/A
9/30/201841-39-43-36N/A
6/30/201840-37-41-34N/A
3/31/201838-33N/A-33N/A
12/31/201736-31N/A-29N/A
12/31/201630-23N/A-25N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if VAPO's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if VAPO's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if VAPO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if VAPO's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if VAPO's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VAPO's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/19 22:39
End of Day Share Price 2024/09/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vapotherm, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert HopkinsBofA Global Research
Michael GormanBTIG
William PlovanicCanaccord Genuity